Neuren Pharmaceuticals Limited (ASX:NEU)
13.18
+0.85 (6.89%)
May 14, 2025, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 1.54 billion as of May 14, 2025. Its market cap has decreased by -37.22% in one year.
Market Cap
1.54B
Enterprise Value
1.32B
Revenue
216.83M
Ranking
n/a
PE Ratio
11.35
Stock Price
13.18
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.54B, an increase of 7,274.71%. That is a compound annual growth rate of 23.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 113.86B |
Pro Medicus | 26.55B |
Cochlear | 17.38B |
Sonic Healthcare | 12.72B |
Ramsay Health Care | 8.39B |
Telix Pharmaceuticals | 8.27B |
Ansell | 4.61B |
Regis Healthcare | 2.24B |